| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
527 |
| issn |
1525-0016 |
| issueIdentifier |
4 |
| pageRange |
525-527 |
| publicationName |
Molecular therapy : the journal of the American Society of Gene Therapy |
| startingPage |
525 |
| bibliographicCitation |
Cullen BR. HIV-1 Vif: counteracting innate antiretroviral defenses. Mol Ther. 2003 Oct;8(4):525–7. doi: 10.1016/j.ymthe.2003.08.010. PMID: 14565218. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_444b98587ef685a03c13443c294d1134 |
| date |
200310 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/14565218
https://doi.org/10.1016/j.ymthe.2003.08.010 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21793
https://portal.issn.org/resource/ISSN/1525-0016 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
HIV-1 Vif: Counteracting Innate Antiretroviral Defenses |
| discusses |
http://id.nlm.nih.gov/mesh/M0024983
http://id.nlm.nih.gov/mesh/M0024984
http://id.nlm.nih.gov/mesh/M0018809
http://id.nlm.nih.gov/mesh/M0005569
http://id.nlm.nih.gov/mesh/M000614859
http://id.nlm.nih.gov/mesh/M0438216
http://id.nlm.nih.gov/mesh/M0017890
http://id.nlm.nih.gov/mesh/M0015060 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D016346Q000502
http://id.nlm.nih.gov/mesh/D015497Q000502
http://id.nlm.nih.gov/mesh/D007113Q000276
http://id.nlm.nih.gov/mesh/D014779Q000502 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D016346Q000235
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D014779Q000235
http://id.nlm.nih.gov/mesh/D011506Q000502
http://id.nlm.nih.gov/mesh/D000071480
http://id.nlm.nih.gov/mesh/D015497Q000276
http://id.nlm.nih.gov/mesh/D015497Q000235
http://id.nlm.nih.gov/mesh/D009700
http://id.nlm.nih.gov/mesh/D016346Q000276
http://id.nlm.nih.gov/mesh/D014779Q000276
http://id.nlm.nih.gov/mesh/D054320
http://id.nlm.nih.gov/mesh/D003564
http://id.nlm.nih.gov/mesh/D012097 |